Clinical Practice Session

Update on Acute Dialytic Modalities in Nephrology: What Are the Data?

November 10, 2019 | 10:00 AM - 12:00 PM

Location: 151, Walter E. Washington Convention Center

Session Description

Acute dialytic therapies are used primarily for AKI and its severe complications. However, RRT has been employed for less traditional indications, such as severe sepsis without advanced AKI to remove cytokines, severe rhabdomyolysis to clear myoglobin, and aggressive tumor lysis syndrome to control the associated metabolic tsunami. High cut-off hemodialysis for patients with cast nephropathy and AKI is another modality considered a potential therapy for myeloma patients. In addition, acute peritoneal dialysis is now being used more commonly for AKI and emergent-start ESRD.

Learning Objective(s)

  • Describe the potential utility of high cut-off dialysis for myeloma cast nephropathy
  • Discuss the utility of extracorporeal therapies for sepsis without AKI
  • Describe the utility of CRRT for rhabdomyolysis and tumor lysis syndrome
  • Explain the role of peritoneal dialysis for AKI and urgent-start ESRD

Learning Pathway(s)

  • Acute Kidney Injury
  • Dialysis

Moderator(s)

  • Luis A. Juncos, MD, FASN
  • Ashita J. Tolwani, MD, MS

Presentations